Building a Bridge to Better Medicine
Scientific Expertise
Our scientific expertise in metabolic and autoimmune diseases has been recognized by awards of >$25MM in federally funded grants since 1996.
Biomere’s reputation for scientific excellence is the foundation on which we have grown a discovery-based preclinical CRO.
Personalized Approach
Our culture fosters personal relationships with our sponsors who regard us not as clients but as collaborators and partners.
Our people are your team. We are focused on delivering the highest quality service and science delivering what you want, when you want it.
Customized Service
Being a lab exclusively dedicated to helping clients with discovery requires Biomere to put a premium on flexibility and adaptability.
Service isn’t just part of a marketing campaign, it’s what we do, who we are. It's not only a promise, but our guarantee.
Fast Turnaround
Biomere takes great pride in being the most responsive preclinical CRO in the industry.
Regardless of where in the process, Biomere places speed and ease of work with us at a premium.
Put our experienced team of experts to work for you!
Preclinical Models
Meet Our Team
Biomere’s leadership and senior scientists are recognized experts and industry veterans. Supporting our scientific leaders is a team of study directors and research technicians all dedicated and focused on delivering the highest quality service in the industry.
Mark Nedelman
CEO
Mark Nedelman is a drug development and CRO veteran with more than 30 years experience.
Christian Grant
Scientific Director of NHP Program
Dr. Grant brings over 10 years of preclinical scientific and project management experience in PK/PD, immunology, and virology.
Barak Yahalom
Scientific Director
Dr. Yahalom is a laboratory animal science professional, veterinarian and research scientist.
April Hall
Vice President, Business Development